Early Intervention in Allergic Patients

NCT05040828 PHASE4 COMPLETED

As many as 250 million people suffer from allergic rhinitis in China, which has a large population, early use of drugs may help better control the symptoms.This study aimed to investigate the effects of early interventional treatment with the leukotriene receptor antagonist (LTRA) montelukast on seasonal allergic rhinitis.

Details

Lead sponsor	Beijing Tongren Hospital
Phase	PHASE4
Status	COMPLETED
Enrolment	59
Start date	Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Allergic Rhinitis Due to Weed Pollen
• Montelukast

Interventions

• Start taking Montelukast Sodium Tablets 10mg quaque die orally two weeks before peak pollen count.
• Montelukast Sodium Tablets 10mg quaque die orally was administered after peak pollen count.
• No oral drug therapy throughout the pollen period

Countries

China